Suppr超能文献

健康计划通过推广仿制药的项目来控制药品成本的增长。

Health plans keeping drug cost increases in check with programs that promote generics.

出版信息

Capitation Manag Rep. 2002 Jul;9(7):101-3, 97.

Abstract

To counter the massive amount of drug company detailing and marketing that is partly responsible for driving up pharmaceutical costs, health plans and some independent practice associations are promoting the use of generics to physicians in their networks. While most physicians in capitated contracts don't directly benefit from the movement to encourage generics unless they have pharmacy risk, some health plans are paying physicians financial incentives to increase generic prescribing.

摘要

为应对制药公司大量的药品推广和营销活动(这些活动在一定程度上导致了药品成本的上升),健康计划机构和一些独立执业医师协会正在向其网络内的医生推广使用通用名药物。虽然参与按人头付费合同的大多数医生不会直接从鼓励使用通用名药物的行动中受益,除非他们承担药房风险,但一些健康计划机构正在向医生提供经济激励,以增加通用名药物的处方量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验